Why pharma companies need to upgrade their intelligence - Pharmaphorum

In the 21st century pharma companies face novel challenges. Pairing artificial intelligence (AI) capabilities with human strengths can bring a competitive edge in this rapidly–changing world. As the Nobel-prize-winning economist Daniel Kahneman wrote in his book Thinking, Fast and Slow, "Intelligence is not only the ability to reason; it is also the ability to find relevant material in memory and to deploy attention when needed." Current Artificial Intelligence (AI) software is not at a point where it can reason independently (often termed'Third Wave AI'). However, it can certainly extend pharmaceutical intelligence, thereby preserving human attention for creative problem-solving and making drug-development cycles more efficient.